IoannisEconomouMD

Gastroenterology • Evanston, IL

Inflammatory Bowel Disease, Clinical Pharmacology

Director, Inflammatory Bowel Disease Program

Join to view full profile

Dr. Economou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Economou's full profile

Already have an account?

Office
1000 Central St. Suite 800
Evanston, IL 60201
Phone+1 847-657-1900

Fax+1 847-733-5041
Is this information wrong?

Education & Training

Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Gastroenterology, 2006 - 2009
Cleveland Clinic FoundationFellowship, Inflammatory Bowel Disease, 2005 - 2006
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2005
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2002 - 2003
Ruprecht Karl University Faculty of MedicineClass of 1999

Certifications & Licensure

IL State Medical License 2017 - 2026
NY State Medical License 2015 - 2025
NJ State Medical License 2006 - 2023
CT State Medical License 2009 - 2015
OH State Medical License 2005 - 2006
American Board of Internal Medicine Gastroenterology

Clinical Trials

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis Start of enrollment: 2015 Jun 17
Completed
Phase 3
Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics Start of enrollment: 2015 Dec 03
Completed
Phase 3
A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis Start of enrollment: 2016 Jan 13
Completed
Phase 1
Entyvio (Vedolizumab) Long Term Safety Study Start of enrollment: 2015 Mar 24
Completed
A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease Start of enrollment: 2016 May 18
Active, not recruiting
Phase 2
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease Start of enrollment: 2016 Aug 25
Completed
Phase 2
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) Start of enrollment: 2017 Jan 31
Active, not recruiting
Phase 3
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease Start of enrollment: 2018 Feb 27
Recruiting
Phase 3
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year Start of enrollment: 2018 Mar 29
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
Priya Sehgal, Steven Su, John Zech, Yael Nobel, Lyndon Luk, Ioannis Economou, Bo Shen, James D Lewis, Daniel E Freedberg> ;Inflammatory Bowel Diseases. 2024 Apr 3
1 citations
Acute Pancreatitis with Colonic Pseudo-obstruction in a Patient with COVID-19.
Jeremy Van, Jason Kramer, Ioannis Economou> ;Case Reports in Gastroenterology. 2022 Mar 1
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals.
Uzzan, M.,Tokuyama, M.,Rosenstein, A. K.,Tomescu, C.,SahBandar, I. N.,Ko, H. M.,Leyre, L.,Chokola, A.,Kaplan-Lewis, E.,Rodriguez, G.,Seki, A.,Corley, M. J.,Aberg, J.,L...> ;Sci Transl Med. 2018 Oct 05
2 citations
IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
Peter N. Le, Julia B. Greer, Ioannis Oikonomou, Wolfgang H. Schraut, Corey A. Siegel, Raymond K. Cross, Stefan D. Holubar, Andrew Tinsley, Walter A. Koltun, David G. B...> ;Inflammatory Bowel Diseases. 2015 Jun 1
46 citations
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.
Gil Y. Melmed, William M. Pandak, Kevin Casey, Bincy Abraham, John F. Valentine, David A. Schwartz, Dahlia Awais, Issac Bassan, Simon Lichtiger, Bruce E. Sands, Stephe...> ;Inflammatory Bowel Diseases. 2015 Aug 1
40 citations
Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients
Adam V. Weizman, Brian Huang, Dror Berel, Stephan R. Targan, Marla Dubinsky, Phillip Fleshner, Andrew Ippoliti, Manreet Kaur, Deepa Panikkath, S Brant, Ioannis Oikonom...> ;Inflammatory Bowel Diseases. 2014 Mar 1
86 citations
The influence of depression on quality of life in patients with inflammatory bowel disease.
Clarence K. Zhang, Jennifer Hewett, Jason Hemming, Taneisha Grant, Hongyu Zhao, Clara Abraham, Ioannis Oikonomou, Meera Kanakia, Judy H. Cho, Deborah D. Proctor> ;Inflammatory Bowel Diseases. 2013 Jul 1
29 citations
Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis.
Bo Shen, Feza H. Remzi, Ioannis Oikonomou, Hong Lu, Bret A. Lashner, Jeffrey P. Hammel, Mario Skugor, Ana E. Bennett, Aaron Brzezinski, Elaine Queener, Victor W. Fazio> ;The American Journal of Gastroenterology. 2009 Mar 1
79 citations
Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.
Bo Shen, Victor W. Fazio, Feza H. Remzi, Ana E. Bennett, Rocio Lopez, Aaron Brzezinski, Ioannis Oikonomou, Kerry K. Sherman, Bret A. Lashner> ;Diseases of the Colon and Rectum. 2007 Feb 5
75 citations
Risk Factors for Clinical Phenotypes of Crohn's Disease of the Ileal Pouch
Bo Shen, Victor W. Fazio, Feza H. Remzi, Ana E. Bennett, Aaron Brzezinski, Rocio Lopez, Ioannis Oikonomou, Kerry K. Sherman, Bret A. Lashner> ;The American Journal of Gastroenterology. 2006 Dec 1
24 citations
Risk Factors for Anemia in Patients with Ileal Pouch-Anal Anastomosis
Ioannis Oikonomou, Victor W. Fazio, Feza H. Remzi, Rocio Lopez, Bret A. Lashner, Bo Shen> ;Diseases of the Colon and Rectum. 2007 Jan 1
2 citations
Are we moving forward in the biological treatment of Crohn's disease? time will tell
Ioannis Oikonomou, Bo Shen> ;Inflammatory Bowel Diseases. 2006 Feb 1
Putting the puzzle together: inherited cancer risk in Crohn's disease patients.
Ioannis Oikonomou, Bret A. Lashner> ;Digestive and Liver Disease. 2006 Jan 1
Selective PCR: a novel internal amplification control strategy for enhanced sensitivity in Salmonella diagnosis.
Oikonomou, I., Halatsi, K., Kyriacou, A.> ;Lett Appl Microbiol. 2008 Apr
Fecal microflora of Greek healthy neonates.
Mitsou, E. K., Kirtzalidou, E., Oikonomou, I., Liosis, G., Kyriacou, A.> ;Anaerobe. 2008 Apr
PCR detection of Salmonella spp. using primers targeting the quorum sensing gene sdiA.
Halatsi, K., Oikonomou, I., Lambiri, M., Mandilara, G., Vatopoulos, A., Kyriacou, A.> ;FEMS Microbiol Lett. 2006 Jun
Inherited metabolic liver disease.
Schilsky, M. L., Oikonomou, I.> ;Curr Opin Gastroenterol. 2005 May
Join now to see all